At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 47 enrolled
Drug / intervention
NVXT Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Assess the Safety and Efficacy of NVXT Solution in Patients With Mild-to-Moderate Fungal Infection of the Toe Nail
In Brief
A Phase 2 clinical trial evaluating NVXT Solution and Vehicle of test product for Onychomycosis. Completed, enrolled 47 participants.
Detailed Summary
This study will examine the safety, tolerability and efficacy of NVXT in a new formulation in patients with mild-to-moderate fungal infection of the toe nail.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnychomycosis
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedJan 2015
Primary CompletionJan 2016
TodayJul 2026
First PostedJan 22, 2015
Enrollment StartDec 1, 2014
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 11.4 years ago
Interventions
NVXT Solutiondrug
NVXT Solution, applied to infected toe nails and 0.5 mm of adjacent skin once daily for 60 days.
Vehicle of test productdrug
Vehicle of test product applied to infected toe nails and 0.5 mm of adjacent skin once daily for 60 days.